Literature DB >> 3806138

Calmodulin content in human brain tumors.

L Frattola, R Piolti, I Appollonio, N Canal, S M Gaini, F Tamma, M Trabucchi.   

Abstract

Using a radioimmunoassay method, the particulate and soluble calmodulin levels were determined in biopsied specimens from normal human brain and from various human brain tumors. Both in normal and pathological tissues the major portion of calmodulin was revealed in the cytosol. The chromatographic elution profiles of calmodulin obtained from soluble and particulate fractions of the same specimen were identical, thus suggesting an identity of the supernatant and particulate form of calmodulin. In all the examined oncotypes, the calmodulin content was lower than in normal extracts and this biochemical feature could not have been correlated with the degree of malignancy of the neoplasia. Furthermore, the translocation of calmodulin from the particles to the cytoplasm, reported in other rapidly growing tumors, lacks in human cerebral ones. Our findings indicate that in human brain oncotypes the calmodulin distribution is quite different from that found in tumors taken from other tissues, where its level is increased and a positive correlation between calmodulin concentration and growth rate of neoplastic tissue has been revealed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3806138     DOI: 10.1016/0022-510x(87)90207-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  1 in total

1.  Evidence for a calmodulin inhibitory substance(s) isolated from human meningiomas.

Authors:  S D Antle; A K Ho; U P Kalyan-Raman
Journal:  J Neurooncol       Date:  1993-06       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.